Windtree Therapeutics Leverages Heart Failure Asset Istaroxime in Multiple Indications Windtree Therapeutics Chief Executive Officer
Why strong technicians are the key to a strong business What it means to be a strong business When measuring the strength of a business, there are nearly limitless metrics available to measure strength. Sales figures, capital, market share, and
Montgomery College’s BioTrain Offers Engaging and Valuable Professional Development Programming for Life Science Professionals BioTrain™ is a sector partnership of biotechnology companies, government entities, and nonprofit organizations led by Montgomery College that collaborates to shape a technical workforce that is
5 Questions with Alia Poonawala, Executive Director, Hire Hopkins "5 Questions With..." is a weekly BioBuzz series where we reach
WindMIL Therapeutics Appoints Dr. Kimberly Noonan as Chief Science & Technology Officer PHILADELPHIA and BALTIMORE, May 06, 2021 (GLOBE NEWSWIRE)
Matan Signs Deal with Ellume for Two Full Buildings at Progress Labs at Center 85
Adaptive Phage Therapeutics Announces $40.75 Million Series B Financing GAITHERSBURG, MD., May 11, 2021 – Adaptive
